MedPath

EMA Approvals

European Medicines Agency approved drug marketing authorisations and regulatory information

European Medicines Agency
European Union
1,709 Approvals
Showing 21 to 40 of 1,709 approvalsPage 2 of 86

Kostaive

Authorisation: Feb 12, 2025

Kostaive

Authorisation: Feb 12, 2025

Andembry

Authorisation: Feb 10, 2025

Hetronifly

Authorisation: Feb 3, 2025

Hetronifly

Authorisation: Feb 3, 2025

Hetronifly

Authorisation: Feb 3, 2025

Lazcluze

Authorisation: Jan 20, 2025

Lazcluze

Authorisation: Jan 20, 2025

Gohibic

Authorisation: Jan 13, 2025

Augtyro

Authorisation: Jan 13, 2025

Siiltibcy

Authorisation: Jan 13, 2025

Alhemo

Authorisation: Dec 13, 2024

Imuldosa

Authorisation: Dec 12, 2024

Absimky

Authorisation: Dec 12, 2024

Hympavzi

Authorisation: Nov 18, 2024

Fluad

Authorisation: Nov 15, 2024

Fluad

Authorisation: Nov 15, 2024

Elahere

Authorisation: Nov 14, 2024

Pomalidomide Teva

Authorisation: Nov 14, 2024

Yuvanci

Authorisation: Sep 27, 2024

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.